What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
Val J. Lowe spends much of his time researching Positron emission tomography, Alzheimer's disease, Pathology, Internal medicine and Nuclear medicine.
His Positron emission tomography research is under the purview of Radiology.
The concepts of his Alzheimer's disease study are interwoven with issues in Apolipoprotein E, Dementia, Neurodegeneration and Amyloidosis.
His Pathology study combines topics from a wide range of disciplines, such as Biomarker and Magnetic resonance imaging.
His Internal medicine study incorporates themes from Endocrinology, Oncology, Cardiology, Gastroenterology and Posterior cingulate.
His research integrates issues of Diagnostic accuracy, Tomography and Malignancy in his study of Nuclear medicine.
His most cited work include:
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. (828 citations)
- Recommendations on the Use of 18F-FDG PET in Oncology (756 citations)
- 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. (735 citations)
What are the main themes of his work throughout his whole career to date?
Val J. Lowe mostly deals with Internal medicine, Pathology, Positron emission tomography, Nuclear medicine and Radiology.
His Internal medicine research incorporates themes from Oncology and Cardiology.
His Pittsburgh compound B, Atrophy, Disease, Dementia with Lewy bodies and Amyloid study are his primary interests in Pathology.
He combines subjects such as Stage, Magnetic resonance imaging and Neuroimaging with his study of Positron emission tomography.
His research combines Malignancy and Nuclear medicine.
The various areas that Val J. Lowe examines in his Radiology study include Cancer, Prostate cancer and Respiratory disease.
He most often published in these fields:
- Internal medicine (24.34%)
- Pathology (22.62%)
- Positron emission tomography (19.66%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (24.34%)
- Pathology (22.62%)
- Disease (13.57%)
In recent papers he was focusing on the following fields of study:
Val J. Lowe mainly investigates Internal medicine, Pathology, Disease, Dementia and Oncology.
His work deals with themes such as Standardized uptake value and Cardiology, which intersect with Internal medicine.
His study in the field of Autopsy and Atrophy also crosses realms of Fumarylacetoacetate hydrolase and Mesenteric lymph nodes.
His studies deal with areas such as Neuroscience and Pediatrics as well as Disease.
His Dementia study combines topics in areas such as Entorhinal cortex, Putamen and Amyloidosis.
Positron emission tomography is the topic of his studies on Nuclear medicine and Radiology.
Between 2018 and 2021, his most popular works were:
- Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. (117 citations)
- Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging-Alzheimer's Association Research Framework. (70 citations)
- Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia (70 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
The scientist’s investigation covers issues in Internal medicine, Positron emission tomography, Pathology, Dementia and Standardized uptake value.
His research links Oncology with Internal medicine.
In his research, Cognitive decline and Amyloid is intimately related to Amyloidosis, which falls under the overarching field of Oncology.
His Positron emission tomography study is concerned with the larger field of Nuclear medicine.
His Dementia course of study focuses on Cohort study and Magnetic resonance imaging, Asymptomatic and Longitudinal study.
The Alzheimer's disease study combines topics in areas such as Biomarker and Dementia with Lewy bodies.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
